Clinical Trial Update: Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in Adults [Phase 1]

View source ↗

Summary

A Phase 1 dose-ranging study of an investigational yellow fever vaccine in adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Yellow Fever

Drugs mentioned

• Investigational Yellow Fever Candidate Vaccine

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Yellow Fever (Healthy Volunteers) | Phase 1 | Status: COMPLETED